Answers are grounded in this paper and cite their sources.
These data provide the first evidence of Nrf2 pathway activation from two large pivotal Phase 3 studies of DMF-treated MS patients.
No takes yet. Share an insight, caveat, or question.
Gopal et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: